Breaking News

Scientists Withdrew The Study, Saying That Anti-Malarial Drugs Increase The Risk Of Heart Disease

The authors retracted their study that said a malaria drug introduced by U.S. President Donald Trump to treat and prevent coronavirus increases the risk of heart side effects and death.

The study was published May 22 in the journal Lancet, a prestigious British medical journal. Questions were soon raised about the accuracy of the baseline data, researchers led by Mandeep Mehra, medical director of Brigham and Women's Hospital Heart and Cardiology Center, in the review published by the magazine on Thursday 4-6.

While the original data producer, Surgisphere Corp, had signaled that they would partner with an independent review, eventually gave up and said doing so would violate a confidentiality agreement, the authors study wrote. 
"Therefore, our critics cannot conduct independent and private reviews." 

the authors said.
"We deeply apologize to you, the editors and readers of the magazine for any confusion or inconvenience this may have caused." the authors wrote.
The withdrawal is the latest turning point for a drug that has been followed by controversy since Trump introduced it as a possible coronavirus treatment earlier this year. Repeated efforts have been made to study this drug and whether it can be used as a therapy for patients with disease or as a preventive measure.

So far, the results have been mostly negative. A large study published this week examining the use of the drug as a preventive measure suggests that it did not prevent the risk of coronavirus infection.

Controversy has also intensified around Surgisphere, a Chicago-based medical data firm that says it consolidates medical records from around the world. The company's data was used in another major study of heart medications called ACE inhibitors and the effect of their use on Covid-19 patients.

No comments